| Financial Year |
March 31 2023 |
| Monetary Funds |
788,400,877.61 |
| Held-for-trading Financial Assets |
50,040,138.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
146,578,729.40 |
| Advances to Suppliers |
124,358,915.93 |
| Other Receivables |
13,948,412.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
164,803.95 |
| Dividend Receivable |
-- |
| Inventories |
431,625,823.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,240,135.79 |
| Total Current Assets |
1,602,193,034.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,616,995.44 |
| Investment Properties |
-- |
| Fixed Assetes |
578,911,698.32 |
| Under-construction Projects |
351,164,434.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,098,927.93 |
| R&D expenses |
-- |
| Goodwill |
86,843,982.20 |
| Long-Term Deferred and Prepaid Expenses |
22,762,097.48 |
| Deferred Income Tax Assets |
2,040,231.05 |
| Other Non-Current Assets |
11,590,119.30 |
| Sub-Total of Non-Current Assets |
1,228,950,317.03 |
| Total Assets |
2,831,143,351.40 |
| Short-Term Loans |
117,906,933.02 |
| Trading Financial liabilities |
1,950,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
97,884,235.47 |
| Accounts Received In Advance |
4,294,447.84 |
| Employee Compensation Payable |
11,060,381.24 |
| Taxes Payable |
6,496,179.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,569,708.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
601,977.22 |
| Other Current Liabilities |
4,509,032.70 |
| Sub-Total of Current Liabilities |
264,956,847.95 |
| Long-term Loans |
5,344,120.91 |
| Bonds Payable |
633,022,341.74 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,682,718.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
694,870,157.13 |
| Total Liabilities |
959,827,005.08 |
| Paid-In Capital(Or Share Stock) |
253,420,280.00 |
| Capital Surplus |
960,204,827.61 |
| Surplus Reserve |
59,658,595.37 |
| LESS:Treasury Stock |
50,563,114.25 |
| Undistributed Profits |
461,176,654.20 |
| Minority Stockholder's Interest |
20,215,071.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,851,101,275.28 |
| Owner's Equity（Stockholder's Equity） |
1,871,316,346.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,831,143,351.40 |
